Hypermethylation status, miRNA profile or driver genes mutations, as TP53, ZNRF3, β-catenin constitute valuable candidates that could integrate a future clinico-molecular prognostic classification of ACC patients (Assié et al., 2014a). Here, ZNRF3 is linked to adrenal cortex carcinoma.